샘플 요청 목록

 카트 문의
시장보고서
상품코드
1731959

세계의 빌리루빈 측정기 시장

Bilirubin Meters
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 454 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 빌리루빈 측정기 시장은 2030년까지 19억 달러에 달할 전망

2024년에 13억 달러로 추정된 빌리루빈 측정기 시장은 2030년에는 19억 달러에 달하며, 분석 기간인 2024-2030년의 CAGR은 6.8%로 성장할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 벤치탑 빌리루빈 측정기는 CAGR 7.9%를 기록하며, 분석 기간 종료까지 13억 달러에 달할 것으로 예측됩니다. 경피 빌리루빈 측정기 부문의 성장률은 분석 기간에 CAGR 4.3%로 추정됩니다.

미국 시장은 3억 4,130만 달러로 추정, 중국은 CAGR 10.8%로 성장 예측

미국의 빌리루빈 측정기 시장은 2024년에 3억 4,130만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 분석 기간인 2024-2030년의 CAGR을 10.8%로 2030년까지 3억 8,960만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 3.3%와 6.6%로 예측됩니다. 유럽에서는 독일이 CAGR 4.5%로 성장할 것으로 예측됩니다.

세계의 빌리루빈 측정기 시장 - 주요 동향과 촉진요인 정리

빌리루빈 측정기가 신생아 및 간 헬스케어에서 임상적으로 중요한 이유는 무엇인가?

빌리루빈 측정기는 임상 진단, 특히 신생아 황달 및 간 관련 질환의 조기 발견 및 모니터링에 있으며, 점점 더 필수적인 요소가 되고 있습니다. 이러한 장비는 혈액 또는 경피적 스크리닝을 통해 빌리루빈 농도를 신속하고 비침습적 또는 저침습적으로 측정할 수 있는 수단을 제공하여 간 기능, 용혈 및 대사 제거에 대한 적시에 인사이트를 제공합니다. 신생아 고빌리루빈혈증은 신생아에서 가장 흔한 임상 증상 중 하나이기 때문에 빌리루빈 측정기를 이용한 조기 선별검사는 카니텔러스 및 빌리루빈 유발 신경 기능 장애(BIND)와 같은 합병증을 예방하는 데 매우 중요합니다.

빌리루빈 측정기는 신생아 의료 외에도 성인의 간 기능 장애, 담도 폐쇄, 용혈성 질환을 모니터링하는 데에도 활용되고 있습니다. 전 세계에서 모자보건 프로그램의 조기 개입을 우선시하는 추세와 함께 현장 진단에 대한 중요성이 강조되면서 병원, 분만센터, 소아과 외래에서 빌리루빈 측정기의 채택이 증가하고 있습니다. 의료 서비스 프로바이더들이 시간을 단축하고 환자 처리 능력을 향상시킬 수 있는 실시간 빌리루빈 평가 툴을 찾고 있으므로 이러한 측정기는 최전방 진단 자산으로서 그 중요성이 커지고 있습니다.

기술 강화와 워크플로우 통합은 빌리루빈 측정기의 성능을 어떻게 향상시키고 있는가?

빌리루빈 측정기의 기술 발전은 측정 정확도, 사용자 편의성 및 진단의 일관성을 향상시켰습니다. 현재 경피 빌리루빈 측정기는 첨단 분광광도법과 다파장 광학 센서를 사용하여 비침습적으로 빌리루빈 농도를 감지하여 신생아에서 채혈의 필요성을 최소화합니다. 이 기기들은 다양한 피부색, 임신 기간, 임상 상태에 걸쳐 재현성 있는 측정이 가능하도록 설계되어 신생아 중환자실 및 산후조리원에서의 보급을 지원하고 있습니다.

터치스크린 인터페이스, 자동 보정 기능, 무선 연결 기능을 갖춘 휴대용 휴대용 모델은 전자건강기록(EHR) 및 병원 정보 시스템에 쉽게 통합할 수 있습니다. 데이터 로깅 기능을 갖춘 배터리 구동식 설계는 이동성을 향상시켜 지방 아웃리치 프로그램, 외래 환경 및 가정내 신생아 모니터링에 사용할 수 있도록 합니다. 제조업체들은 또한 소형화, 센서의 정확도 향상, 빌리루빈 측정과 헤모글로빈 및 산소포화도 파라미터를 결합한 이중 기능 모델에 중점을 두어 소아과 및 간 질환 진단 워크플로우에서 유용성을 넓히고 있습니다.

빌리루빈 측정기 수요가 증가하고 있는 곳은 어디이며, 어떤 의료현장에서 채택이 진행되고 있는가?

황달의 조기 발견을 지원하는 보편적인 신생아 선별검사 프로토콜과 탄탄한 임상 인프라를 갖춘 북미와 유럽과 같은 신흥 시장에서 수요가 가장 많이 증가하고 있습니다. 아시아태평양은 높은 출산율, 신생아 의료 접근성 확대, 주산기 합병증에 대한 공중보건 노력으로 인해 고성장 지역으로 부상하고 있습니다. 인도, 중국, 인도네시아, 베트남 등의 국가에서는 예방 가능한 영유아의 이환율과 사망률을 낮추기 위해 공공 및 민간 의료 시설에서 빌리루빈 측정기 조달이 증가하고 있습니다.

1차적인 채택은 신생아 중환자실(NICU), 산부인과 병원, 소아과 클리닉에 집중되어 있습니다. 또한 지역 보건 프로그램이나 조산원 네트워크에서는 산후 가정 방문시 조기 검진을 위해 휴대용 빌리루빈 측정기를 구비하는 곳이 늘고 있습니다. 성인 의료 분야에서는 간 질환 클리닉과 간 이식 센터가 간 기능 패널 진단의 일환으로 실험실 기반 빌리루빈 분석기에 의존하고 있습니다. 전 세계에서 보편적 건강 보장 및 지역 건강 형평성에 대한 노력이 강화되고 있는 가운데, 정확한 빌리루빈 모니터링에 대한 분산형 접근은 진단 역량 구축의 중요한 요소가 되고 있습니다.

빌리루빈 측정기 시장의 세계 성장 원동력은?

빌리루빈 측정기 시장의 세계 성장의 원동력은 신생아 의료 수준 향상, 모자보건의 우선순위 설정, 황달 발견 지연으로 인한 결과에 대한 인식 증가입니다. 기술 혁신, 비침습적 스크리닝 툴에 대한 규제 지원, 모바일 헬스 플랫폼과의 통합을 통해 이러한 장비는 고자원 및 저자원 의료 시스템 모두에서 보다 쉽게 접근하고 확장할 수 있게 되었습니다. 또한 더 빠른 진단과 개입을 위해 병상에서의 실시간 검사로 임상이 전환되고 있는 것도 수요를 촉진하고 있습니다.

민관 파트너십, 국제 보건 단체를 통한 기부, 영유아 보건 프로그램을 통한 정부 조달 증가로 신흥 경제국에서 시장 침투가 가속화되고 있습니다. 제조업체들은 일선 의료진을 위해 설계되고 사용하기 쉽고 유지보수가 간편한 모델로 제품군을 확장하고 있습니다. 환자 안전, 조기 개입 및 진단의 분산화는 계속해서 헬스케어의 우선순위를 형성하면서 중요한 의문이 제기되고 있습니다. 빌리루빈 측정기 시장이 비침습적이고 정밀한 비침습적 솔루션을 통해 보편적인 신생아 선별검사와 전 세계 의료 생태계 전반에 걸친 광범위한 간 기능 모니터링을 지원할 수 있을 만큼 충분히 빠르게 성장할 수 있는가?

부문

제품(벤치탑, 경피), 적응증(황달, 간염), 연령층(신생아, 성인), 최종사용자(병원 & 요양시설, 클리닉, 기타 최종사용자)

조사 대상 기업의 예(총 34건)

  • Advanced Instruments, LLC
  • Apel Co., Ltd.
  • AVI Healthcare Pvt. Ltd.
  • Danaher Corporation
  • DAS Srl
  • Dragerwerk AG & Co. KGaA
  • F. Hoffmann-La Roche Ltd.
  • Ginevri Srl
  • GPC Medical Ltd.
  • Hadleigh Health Technologies
  • ICEN Technology Company Limited
  • Koninklijke Philips N.V.
  • Labtron Equipment Ltd.
  • Mennen Medical Ltd.
  • Micro Lab Instruments
  • Mindray Bio-Medical Electronics Co., Ltd.
  • Natus Medical Incorporated
  • Ningbo David Medical Device Co., Ltd.
  • Siemens Healthineers AG
  • Xuzhou Kejian Hi-tech Co., Ltd.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 인위적인 수입원가 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

Global Industry Analysts는 세계 주요 수석 이코노미스트(1,4,949명), 싱크탱크(62개 기관), 무역 및 산업 단체(171개 기관)의 전문가들의 의견을 면밀히 검토하여 생태계에 미치는 영향을 평가하고 새로운 시장 현실에 대응하고 있습니다. 모든 주요 국가의 전문가와 경제학자들이 관세와 그것이 자국에 미치는 영향에 대한 의견을 추적 조사했습니다.

Global Industry Analysts는 이러한 혼란이 향후 2-3개월 내에 마무리되고 새로운 세계 질서가 보다 명확하게 확립될 것으로 예상하고 있으며, Global Industry Analysts는 이러한 상황을 실시간으로 추적하고 있습니다.

2025년 4월: 협상 단계

이번 4월 보고서에서는 관세가 세계 시장 전체에 미치는 영향과 지역별 시장 조정에 대해 소개합니다. 당사의 예측은 과거 데이터와 진화하는 시장 영향요인을 기반으로 합니다.

2025년 7월: 최종 관세 재설정

고객님들께는 각 국가별 최종 리셋이 발표된 후 7월에 무료 업데이트 버전을 제공해 드립니다. 최종 업데이트 버전에는 명확하게 정의된 관세 영향 분석이 포함되어 있습니다.

상호 및 양자 간 무역과 관세의 영향 분석 :

미국 <>중국 <>멕시코 <>캐나다 <>EU <>일본 <>인도 <>기타 176개국

업계 최고의 이코노미스트: Global Industry Analysts의 지식 기반은 국가, 싱크탱크, 무역 및 산업 단체, 대기업, 그리고 세계 계량 경제 상황의 전례 없는 패러다임 전환의 영향을 공유하는 분야별 전문가 등 가장 영향력 있는 수석 이코노미스트를 포함한 14,949명의 이코노미스트를 추적하고 있습니다. 16,491개 이상의 보고서 대부분에 마일스톤에 기반한 2단계 출시 일정이 적용되어 있습니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.06.16

Global Bilirubin Meters Market to Reach US$1.9 Billion by 2030

The global market for Bilirubin Meters estimated at US$1.3 Billion in the year 2024, is expected to reach US$1.9 Billion by 2030, growing at a CAGR of 6.8% over the analysis period 2024-2030. Benchtop Bilirubin Meters, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Transcutaneous Bilirubin Meters segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$341.3 Million While China is Forecast to Grow at 10.8% CAGR

The Bilirubin Meters market in the U.S. is estimated at US$341.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$389.6 Million by the year 2030 trailing a CAGR of 10.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 6.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Bilirubin Meters Market - Key Trends & Drivers Summarized

Why Are Bilirubin Meters Gaining Clinical Importance in Neonatal and Hepatic Health Management?

Bilirubin meters are becoming increasingly essential in clinical diagnostics, particularly for early detection and monitoring of neonatal jaundice and liver-related disorders. These devices offer a rapid, non-invasive or minimally invasive means of measuring bilirubin concentration in blood or through transcutaneous screening-providing timely insight into liver function, hemolysis, and metabolic clearance. As neonatal hyperbilirubinemia remains one of the most common clinical conditions in newborns, early screening using bilirubin meters is critical to preventing complications such as kernicterus and bilirubin-induced neurologic dysfunction (BIND).

In addition to neonatal care, bilirubin meters are being utilized in monitoring hepatic dysfunction, biliary obstruction, and hemolytic diseases in adults. The growing emphasis on point-of-care diagnostics, coupled with the global prioritization of early intervention in maternal and infant health programs, is driving adoption across hospitals, birthing centers, and outpatient pediatric care. As healthcare providers seek real-time bilirubin assessment tools that reduce turnaround times and improve patient throughput, these meters are gaining relevance as frontline diagnostic assets.

How Are Technology Enhancements and Workflow Integration Advancing Bilirubin Meter Performance?

Technological advancements in bilirubin meters are improving measurement accuracy, user convenience, and diagnostic consistency. Transcutaneous bilirubinometers now use advanced spectrophotometry and multi-wavelength optical sensors to detect bilirubin levels non-invasively, minimizing the need for blood draws in neonates. These devices are designed for repeatable measurements across different skin tones, gestational ages, and clinical conditions-supporting widespread adoption in neonatal ICUs and postnatal wards.

Handheld, portable models with touchscreen interfaces, auto-calibration features, and wireless connectivity are facilitating integration into electronic health records (EHRs) and hospital information systems. Battery-operated designs with data logging capabilities enhance mobility and enable use in rural outreach programs, ambulatory settings, and home-based newborn monitoring. Manufacturers are also focusing on miniaturization, sensor precision, and dual-function models that combine bilirubin measurement with hemoglobin or oxygen saturation parameters-broadening their utility within pediatric and hepatic diagnostic workflows.

Where Is Demand for Bilirubin Meters Rising and Which Care Settings Are Driving Adoption?

Demand is strongest in developed markets such as North America and Europe, where universal newborn screening protocols and robust clinical infrastructure support early jaundice detection. Asia-Pacific is emerging as a high-growth region due to high birth rates, expanding neonatal care access, and public health initiatives targeting perinatal complications. Countries such as India, China, Indonesia, and Vietnam are witnessing increased procurement of bilirubin meters in both public and private healthcare facilities to reduce preventable infant morbidity and mortality.

Primary adoption is concentrated in neonatal intensive care units (NICUs), maternity hospitals, and pediatric clinics. Community health programs and midwifery networks are also increasingly equipped with portable bilirubinometers for early screening during postnatal home visits. In adult medicine, hepatology clinics and liver transplant centers rely on lab-based bilirubin analyzers as part of liver function panel diagnostics. With global efforts intensifying around universal health coverage and rural health equity, decentralized access to accurate bilirubin monitoring is becoming a critical component of diagnostic capacity-building.

What Is Fueling the Global Growth of the Bilirubin Meters Market?

The global growth of the bilirubin meters market is being driven by rising neonatal care standards, the prioritization of maternal and child health, and growing awareness of the consequences of delayed jaundice detection. Technological innovation, regulatory support for non-invasive screening tools, and integration with mobile health platforms are making these devices more accessible and scalable across both high- and low-resource healthcare systems. Demand is also reinforced by the clinical shift toward real-time, bedside testing for faster diagnosis and intervention.

Public-private partnerships, donations through global health organizations, and increased government procurement under infant health programs are accelerating market penetration in emerging economies. Manufacturers are expanding product lines with user-friendly, maintenance-light models designed for frontline health workers. As patient safety, early intervention, and diagnostic decentralization continue to shape healthcare priorities, a critical question emerges: Can the bilirubin meter market scale non-invasive, high-accuracy solutions fast enough to support universal newborn screening and broader hepatic health surveillance across global care ecosystems?

SCOPE OF STUDY:

The report analyzes the Bilirubin Meters market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Benchtop, Transcutaneous); Indication (Jaundice, Hepatitis); Age Group (Neonatal, Adults); End-User (Hospitals & Nursing Homes, Clinics, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Advanced Instruments, LLC
  • Apel Co., Ltd.
  • AVI Healthcare Pvt. Ltd.
  • Danaher Corporation
  • DAS Srl
  • Dragerwerk AG & Co. KGaA
  • F. Hoffmann-La Roche Ltd.
  • Ginevri Srl
  • GPC Medical Ltd.
  • Hadleigh Health Technologies
  • ICEN Technology Company Limited
  • Koninklijke Philips N.V.
  • Labtron Equipment Ltd.
  • Mennen Medical Ltd.
  • Micro Lab Instruments
  • Mindray Bio-Medical Electronics Co., Ltd.
  • Natus Medical Incorporated
  • Ningbo David Medical Device Co., Ltd.
  • Siemens Healthineers AG
  • Xuzhou Kejian Hi-tech Co., Ltd.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Bilirubin Meters - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Neonatal Jaundice Drives Global Demand for Point-of-Care Bilirubin Meters
    • Non-Invasive Transcutaneous Meters Gain Preference in Pediatric and Maternity Care Settings
    • Real-Time Bilirubin Monitoring Enhances Early Intervention and Reduces Hospital Readmission
    • Integration With EHRs and Smart Monitoring Platforms Increases Clinical Workflow Efficiency
    • Portable and Handheld Devices Expand Bilirubin Testing in Low-Resource and Rural Healthcare Environments
    • Calibration Accuracy and Phototherapy Threshold Alerts Strengthen Utility in NICU Applications
    • Growth in Home-Based Newborn Care and Midwife Services Increases Use of Compact Bilirubin Meters
    • Regulatory Approvals and Safety Certifications Influence Vendor Selection in Pediatric Units
    • Multi-Parameter Devices Combining Jaundice and Vital Monitoring Improve Adoption in Newborn Bundles
    • Technology Advancements in Optical Sensors Improve Diagnostic Speed and Reliability
    • Public Health Initiatives for Infant Screening Expand Access to Bilirubin Testing in Developing Regions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Bilirubin Meters Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Bilirubin Meters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Bilirubin Meters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Bilirubin Meters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Benchtop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Benchtop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Benchtop by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Transcutaneous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Transcutaneous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Transcutaneous by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Jaundice by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Jaundice by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Jaundice by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hepatitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hepatitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Hepatitis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Neonatal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Neonatal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Neonatal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Adults by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Adults by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Adults by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals & Nursing Homes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals & Nursing Homes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Hospitals & Nursing Homes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Bilirubin Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • JAPAN
    • Bilirubin Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • CHINA
    • Bilirubin Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • EUROPE
    • Bilirubin Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Bilirubin Meters by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Bilirubin Meters by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Bilirubin Meters by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • FRANCE
    • Bilirubin Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 95: France Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: France 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 98: France Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: France 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 101: France Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: France Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: France 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 104: France Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: France Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: France 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • GERMANY
    • Bilirubin Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Germany 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 110: Germany Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Germany Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Germany 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 113: Germany Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Germany Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Germany 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 116: Germany Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Germany Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Germany 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 119: Italy Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Italy Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Italy 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 122: Italy Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Italy Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Italy 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 125: Italy Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Italy Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Italy 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 128: Italy Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Italy Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Italy 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Bilirubin Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 131: UK Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: UK Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: UK 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 134: UK Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: UK Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: UK 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 137: UK Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: UK Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: UK 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 140: UK Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: UK Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: UK 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 143: Spain Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Spain Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Spain 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 146: Spain Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Spain Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Spain 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 149: Spain Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Spain Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Spain 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 152: Spain Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Spain Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Spain 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 155: Russia Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Russia Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Russia 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 158: Russia Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Russia Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Russia 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 161: Russia Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Russia Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Russia 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 164: Russia Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Russia Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Russia 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 167: Rest of Europe Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Europe Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Europe 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 170: Rest of Europe Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Europe Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Rest of Europe 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Rest of Europe Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Rest of Europe 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Europe Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Rest of Europe 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Bilirubin Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 179: Asia-Pacific Recent Past, Current & Future Analysis for Bilirubin Meters by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 180: Asia-Pacific Historic Review for Bilirubin Meters by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Asia-Pacific 15-Year Perspective for Bilirubin Meters by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 182: Asia-Pacific Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Asia-Pacific Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Asia-Pacific 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Asia-Pacific Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Asia-Pacific 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Asia-Pacific Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Asia-Pacific 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Asia-Pacific Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Asia-Pacific 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Bilirubin Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 194: Australia Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Australia Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Australia 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 197: Australia Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Australia Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Australia 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 200: Australia Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Australia Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Australia 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 203: Australia Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Australia Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Australia 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • INDIA
    • Bilirubin Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 206: India Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: India Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: India 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 209: India Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: India Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: India 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 212: India Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: India Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: India 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 215: India Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: India Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: India 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 218: South Korea Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: South Korea Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: South Korea 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 221: South Korea Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: South Korea Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: South Korea 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 224: South Korea Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: South Korea Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: South Korea 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 227: South Korea Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: South Korea Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: South Korea 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 230: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Asia-Pacific Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Asia-Pacific 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 233: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Asia-Pacific Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Asia-Pacific 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Asia-Pacific Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Asia-Pacific 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Asia-Pacific Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Asia-Pacific 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Bilirubin Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 242: Latin America Recent Past, Current & Future Analysis for Bilirubin Meters by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 243: Latin America Historic Review for Bilirubin Meters by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Latin America 15-Year Perspective for Bilirubin Meters by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 245: Latin America Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Latin America Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Latin America 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 248: Latin America Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Latin America Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Latin America 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 251: Latin America Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Latin America Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Latin America 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 254: Latin America Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Latin America Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Latin America 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 257: Argentina Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Argentina Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Argentina 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 260: Argentina Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Argentina Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Argentina 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 263: Argentina Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Argentina Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Argentina 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 266: Argentina Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Argentina Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Argentina 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 269: Brazil Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Brazil Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Brazil 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 272: Brazil Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Brazil Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Brazil 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 275: Brazil Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Brazil Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Brazil 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 278: Brazil Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Brazil Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Brazil 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 281: Mexico Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Mexico Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: Mexico 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 284: Mexico Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Mexico Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: Mexico 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 287: Mexico Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Mexico Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: Mexico 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 290: Mexico Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Mexico Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Mexico 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 293: Rest of Latin America Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Latin America Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Latin America 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Latin America Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Latin America Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Latin America 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 299: Rest of Latin America Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Latin America Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Latin America 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Latin America Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Latin America 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Bilirubin Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 305: Middle East Recent Past, Current & Future Analysis for Bilirubin Meters by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 306: Middle East Historic Review for Bilirubin Meters by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Middle East 15-Year Perspective for Bilirubin Meters by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 308: Middle East Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Middle East Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 310: Middle East 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 311: Middle East Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Middle East Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 313: Middle East 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 314: Middle East Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Middle East Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 316: Middle East 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 317: Middle East Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Middle East Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 319: Middle East 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 320: Iran Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Iran Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 322: Iran 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 323: Iran Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Iran Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 325: Iran 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 326: Iran Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Iran Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 328: Iran 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 329: Iran Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Iran Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 331: Iran 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 332: Israel Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Israel Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 334: Israel 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 335: Israel Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Israel Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 337: Israel 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 338: Israel Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Israel Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 340: Israel 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 341: Israel Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Israel Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 343: Israel 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 344: Saudi Arabia Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Saudi Arabia Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 346: Saudi Arabia 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 347: Saudi Arabia Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Saudi Arabia Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 349: Saudi Arabia 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 350: Saudi Arabia Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Saudi Arabia Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 352: Saudi Arabia 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Saudi Arabia Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 355: Saudi Arabia 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 356: UAE Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 357: UAE Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 358: UAE 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 359: UAE Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 360: UAE Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 361: UAE 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 362: UAE Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 363: UAE Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 364: UAE 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 365: UAE Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 366: UAE Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 367: UAE 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 368: Rest of Middle East Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 369: Rest of Middle East Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 370: Rest of Middle East 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 371: Rest of Middle East Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 372: Rest of Middle East Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 373: Rest of Middle East 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 374: Rest of Middle East Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 375: Rest of Middle East Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 376: Rest of Middle East 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 378: Rest of Middle East Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 379: Rest of Middle East 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • AFRICA
    • Bilirubin Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 380: Africa Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 381: Africa Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 382: Africa 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 383: Africa Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 384: Africa Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 385: Africa 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 386: Africa Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 387: Africa Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 388: Africa 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 389: Africa Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 390: Africa Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 391: Africa 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제